Superhuman' Pre-IPO Stock Trading Under $1

The Flash Report

24 Mar 2026 — 1 min read

Have you heard about this sub $1 Pre-IPO company that is making people "Superhumans"?

It's all thanks to their new product called Visor.

And it's very similar to Jarvis from the movie Iron Man.

Investors are calling this a 'massive breakthrough'.

But not for the reason you think...

Investors have already started flooding in to take advantage of this while the company is still private.

But this opportunity won't be around forever... They've officially reserved a Nasdaq ticker and time is limited to invest at the current valuation.

Don't delay! Click below to see the sub $1 'Superhuman' Pre-IPO AI Stock.

Invest Before the Pre-IPO Round Closes

This is a paid advertisement for Immersed Regulation A+ offering. Please read the offering circular at https://invest.immersed.com/

The Biggest Unsolved Problem in Medicine?

Today, over half a billion people battle osteoarthritis. Each year, they spend $240B trying to halt the destruction of joint cartilage. But no cure exists on the market. Not for lack of trying, either. Big Pharma’s spent billions failing. Thankfully, Cytonics may have cracked the code. They discovered the

What if David and Goliath teamed up instead?

That’s what’s currently playing out in the foodservice industry, where industry goliaths Sodexo, Aramark, and Compass Group all partnered with foodtech startup Automated Retail Technologies. Why did they choose ART? With more than 150,000 venues managed by that trio alone, staffing overnight operations is costly and complicated.

The Key to This $500B Market Is in Your Bloodstream

Every year, $240B is spent on treating the symptoms of osteoarthritis, a disease that leads to joint degradation and, eventually, immobility. With 500M people afflicted, its total addressable market is worth over $500B. But not a single therapy has been able to actually stop it. The answer, it turns out,

This Pre-IPO Stock is Up 4,000% Already

What do you do after 4,000% growth? If you’re Immersed, you build the future. How do you follow 4,000% valuation growth? By preparing for what’s next. That’s what Immersed did, reserving the Nasdaq ticker $IMRS. But the real opportunity for investors is now, before public

Read more

The Biggest Unsolved Problem in Medicine?

What if David and Goliath teamed up instead?

The Key to This $500B Market Is in Your Bloodstream

This Pre-IPO Stock is Up 4,000% Already